Abstract:Objective To explore the risk factors affecting benign and malignant pancreatic cystic neoplasm (PCN) and prognosis of patients.Methods The retrospective caseocontrol study was adopted.The clinicopathological data of 182 patients with PCN who were admitted to the First Affiliated Hospital of Harbin Medical University from February 2001 to February 2011 were collected.Of 182 patients,146 with benign tumors (non-invasive type) were confirmed as adenomas,borderline tumor and carcinoma in situ by pathological examination,and 36 with malignant tumors (invasive type) were confirmed as invasive carcinomas.The follow-up using telephone interview was performed to detect the survival of patients and tumor recurrence once every 3 months up to February 20,2016.The survival time was from the postoperative first day to death or end of follow-up.The analysis indicators included (1) risk factors affecting benign and malignant tumors:age,gender,body mass index (BMI),diabetes,cigarette smoking,alcohol drinking,history of pancreatitis,clinical symptoms,tumor location,tumor diameter,number of tumors,vascular involvement,levels of serum CA19-9 and carcinoembryonic antigen (CEA),(2) risk factors affecting prognosis of patients with malignant tumors.The survival curve was drawn by Kaplan-Meier method.The survival rate was done using the Log-rank test,univariate analysis and multivariate analysis were respectively done by the chi-square test or Fisher exact probility and COX regression model.Results (1) Risk factors affecting benign and malignant tumors:results of univariate analysis showed that age,tumor location,levels of serum CA19-9 and CEA were associated with the incidence of malignant PCN (x2=7.79,6.83,20.55,16.55,P ＜0.05).Results of multivariate analysis showed that age≥60 years and serum CEA≥3.4 μg/L were independent risk factors for the preoperative prediction of malignant PCN [OR =8.012,7.429,95％ confidence interval (CI):1.965-32.678,1.403-39.331,P ＜ 0.05].There was colinearity between level of serum CA19-9 and level of serum CEA by association analysis (x2=12.66,P ＜ 0.05).(2) Risk factors affecting prognosis of patients with malignant tumors:36 patients with malignant PCN were followed up for 60months.The 5-year survival rates of patients with preoperative serum CEA ≥3.4 μg/L and ＜ 3.4 μg/L were 27.3％ and 54.5％,respectively,showing a statistically significant difference (x2=5.83,P ＜ 0.05).Results of the COX regression model showed that preoperative serum CEA ≥ 3.4 μg/L was an independent risk factor evaluating the prognosis of patients with malignant PCN (RR =8.499,95％ CI:2.120-34.066,P ＜ 0.05).Conclusion PCN in patients with age ≥ 60 years,serum CA19-9 ≥ 37 U/L and serum CEA ≥ 3.4 μg/L is considered for malignancy and preoperative CEA level can effectively evaluate the prognosis of patients with malignant PCN.

Are preoperative blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios useful in predicting malignancy in surgically-treated mucin-producing pancreatic cystic neoplasms?

The Value of Systemic Inflammatory Markers in Identifying Malignancy in Mucinous Pancreatic Cystic Neoplasms

Preoperative neutrophil-to-lymphocyte ratio predicts malignancy and recurrence-free survival of solid pseudopapillary tumor of the pancreas.

Validation of Sendai and Fukuoka Consensus Guidelines in Predicting Malignancy in Patients with Preoperatively Diagnosed Mucinous Pancreatic Cystic Neoplasms.

Evaluation of Predictive Factors for Malignancy in Cystic Neoplasms of Pancreas

Efficacy evaluation of the indications for surgery in different guidelines for predicting malignancy of mucinous pancreatic cystic neoplasms

Preoperative Ultrasound Combined with Routine Blood Tests in Predicting the Malignant Risk of Pancreatic Cystic Neoplasms

Preoperative prediction of malignancy of pancreatic cystic neoplasm: a report of 342 cases

Preoperative predictors of malignancy and invasive carcinoma in intraductal papillary mucinous neoplasms

[The Value of Preoperative CA19-9 Combined with Platelet-to-lymphocyte Ratio in Predicting Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms].

Preoperative Neutrophil-to-lymphocyte Ratio and Tumor-Related Factors to Predict Lymph Node Metastasis in Patients with Pancreatic Ductal Adenocarcinoma (PDAC)

Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgically Resectable Pancreatic Neuroendocrine Tumors.

Preoperative Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Stage I-III Gastric Cancer Patients with a MGC Component.

Online calculator for predicting the risk of malignancy in patients with pancreatic cystic neoplasms: A multicenter, retrospective study

Preoperative Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios As Independent Predictors of T Stages in Hilar Cholangiocarcinoma.

The Value of Preoperative NLR and PLR Combined with the Consensus in Surgical Decision Making for Branch Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas

Diagnostic and Prognostic Impact of Neutrophil-to-Lymphocyte Ratio for Intraductal Papillary Mucinous Neoplasms of the Pancreas with High-Grade Dysplasia and Associated Invasive Carcinoma

Intraductal Papillary Mucinous Neoplasms of the Pancreas--predictors of Malignancy.

Malignancy Risk Factors and Prognostic Variables of Pancreatic Mucinous Cystic Neoplasms in Chinese Patients.

Preoperative diagnosis of the malignancy for pancreatic cystic neoplasms

Risk Factors Analysis of Benign and Malignant Pancreatic Cystic Neoplasm and Prognosis